tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Drugs Made In America Acquisition Corp

DMAA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
10.710USD
0.0000.00%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
260.01M์‹œ๊ฐ€์ด์•ก
74.30P/E TTM

Drugs Made In America Acquisition Corp

10.710
0.0000.00%
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ
TradingKey ์ฐจํŠธ
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

0.00%

5์ผ

+0.09%

1๊ฐœ์›”

+0.66%

6๊ฐœ์›”

+2.68%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

+3.28%

1๋…„

+4.28%

ํ•ต์‹ฌ ์ˆ˜์น˜
10.700์‹œ๊ฐ€
10.720์ตœ๊ณ ๊ฐ€
8.53K๊ฑฐ๋ž˜๋Ÿ‰
74.30P/E TTM
--๋™์  P/E ๋น„์œจ
--๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.03%ํšŒ์ „์œจ
10.710์ „์ผ ์ข…๊ฐ€
10.700์ตœ์ €๊ฐ€
88.32K๋งค์ถœ์•ก
์†์‹ค์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
1.54P/B
0.00%๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
2.80%ROA
10.52052์ฃผ ์ตœ๊ณ ๊ฐ€
1.51๊ฑฐ๋ž˜๋Ÿ‰ ๋น„์œจ
-279.85K์ˆœ์ด์ต
33.72M์ฃผ์‹
0.1442์ฃผ๋‹น์ˆœ์ด์ต
--๋ฒ ํƒ€
2.89%ROE
10.02052์ฃผ ์ตœ์ €๊ฐ€
0.19%๋ณ€๋™ ํญ
--์ด ์ด์ต๋ฅ 
260.01M์‹œ๊ฐ€์ด์•ก
3.37๋ณด์ƒ/์œ„ํ—˜
0.14%์œ„ํ—˜๋ฅ 

Drugs Made In America Acquisition Corp ๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์ง€ํ‘œ๎˜

์ง€ํ‘œ
๋งค๋„(1)
์ค‘๋ฆฝ(3)
๋งค์ˆ˜(1)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
0.003
๋งค์ˆ˜
RSI(14)
61.776
์ค‘๋ฆฝ
STOCH(KDJ)(9,3,3)
82.191
์ค‘๋ฆฝ
ATR(14)
0.026
์ €๋ณ€๋™์„ฑ
CCI(14)
88.855
์ค‘๋ฆฝ
Williams %R
12.500
๊ณผ๋งค๋„
TRIX(12,20)
0.025
๋งค๋„
StochRSI(14)
100.000
๊ณผ๋งค๋„
์ด๋™ ํ‰๊ท 
๋งค๋„(0)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(6)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
10.702
๋งค์ˆ˜
MA10
10.696
๋งค์ˆ˜
MA20
10.680
๋งค์ˆ˜
MA50
10.643
๋งค์ˆ˜
MA100
10.588
๋งค์ˆ˜
MA200
10.327
๋งค์ˆ˜

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ด ์ˆ˜์ต

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp ์ •๋ณด๎˜

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
์ข…๋ชฉ ์ฝ”๋“œ DMAA
ํšŒ์‚ฌDrugs Made In America Acquisition Corp
CEOStockwell (Lynn)
์›น์‚ฌ์ดํŠธ

์ฃผ์ฃผ๎˜

์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Drugs Made In America Acquisition LLC
12.42%
Karpus Investment Management
7.53%
First Trust Capital Management L.P.
6.65%
Mizuho Securities USA, LLC.
5.93%
Glazer Capital, LLC
5.39%
๊ธฐํƒ€
62.08%

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Drugs Made In America Acquisition Corp(DMAA)์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp(DMAA)์˜ ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 10.71์ž…๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp์˜ ์ข…๋ชฉ ๊ธฐํ˜ธ(Symbol)๋Š” ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp์˜ ์ข…๋ชฉ ์ฝ”๋“œ๋Š” DMAA์ž…๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” 10.52์ž…๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” 10.02์ž…๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp์˜ ์‹œ๊ฐ€์ด์•ก์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp์˜ ์‹œ๊ฐ€์ด์•ก์€ 361.11M์ž…๋‹ˆ๋‹ค.

Drugs Made In America Acquisition Corp(DMAA)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Drugs Made In America Acquisition Corp(DMAA)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ 0.14์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ